C4orf36
gene geneOn this page
Also known as MGC26744
Summary
C4orf36 (chromosome 4 open reading frame 36, HGNC:28386) is a protein-coding gene on chromosome 4q21.3, encoding Uncharacterized protein C4orf36 (Q96KX1).
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_144645
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28386 |
| Approved symbol | C4orf36 |
| Name | chromosome 4 open reading frame 36 |
| Location | 4q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC26744 |
| Ensembl gene | ENSG00000163633 |
| Ensembl biotype | protein_coding |
| OMIM | 621278 |
| Entrez | 132989 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 9 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000295898, ENST00000462714, ENST00000504008, ENST00000504371, ENST00000506308, ENST00000512468, ENST00000904796, ENST00000904797, ENST00000904798, ENST00000913350, ENST00000913351, ENST00000941964
RefSeq mRNA: 7 — MANE Select: NM_144645
NM_001369888, NM_001369889, NM_001414635, NM_001414636, NM_001414638, NM_001414640, NM_144645
CCDS: CCDS3615
Canonical transcript exons
ENST00000295898 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001196777 | 86876205 | 86876443 |
| ENSE00001196789 | 86892183 | 86892422 |
| ENSE00001322383 | 86887758 | 86887893 |
| ENSE00003815117 | 86891456 | 86891593 |
| ENSE00003823946 | 86888121 | 86888275 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 81.87.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1649 / max 8.1195, expressed in 66 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 52990 | 0.1305 | 45 |
| 52989 | 0.0344 | 6 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.87 | gold quality |
| right testis | UBERON:0004534 | 77.83 | gold quality |
| left testis | UBERON:0004533 | 77.70 | gold quality |
| testis | UBERON:0000473 | 77.21 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.71 | gold quality |
| cortical plate | UBERON:0005343 | 68.90 | gold quality |
| esophagus mucosa | UBERON:0002469 | 68.19 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 67.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 67.02 | gold quality |
| skin of abdomen | UBERON:0001416 | 66.21 | gold quality |
| right lung | UBERON:0002167 | 66.06 | gold quality |
| endocervix | UBERON:0000458 | 65.85 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.91 | gold quality |
| zone of skin | UBERON:0000014 | 64.53 | gold quality |
| left ovary | UBERON:0002119 | 64.35 | gold quality |
| endometrium | UBERON:0001295 | 64.34 | gold quality |
| vagina | UBERON:0000996 | 63.70 | gold quality |
| ectocervix | UBERON:0012249 | 63.59 | gold quality |
| ovary | UBERON:0000992 | 63.46 | gold quality |
| skin of leg | UBERON:0001511 | 63.38 | gold quality |
| prostate gland | UBERON:0002367 | 62.24 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 62.00 | gold quality |
| right ovary | UBERON:0002118 | 61.80 | gold quality |
| uterine cervix | UBERON:0000002 | 61.75 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 61.62 | gold quality |
| thyroid gland | UBERON:0002046 | 61.48 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 61.32 | gold quality |
| frontal cortex | UBERON:0001870 | 61.22 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 60.81 | gold quality |
| urinary bladder | UBERON:0001255 | 60.57 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6058 | no | 8.48 |
| E-ANND-3 | no | 1.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting C4orf36, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-6509-3P | 98.32 | 67.33 | 1343 |
| HSA-MIR-665 | 97.60 | 65.64 | 1781 |
| HSA-MIR-4486 | 96.96 | 60.61 | 931 |
| HSA-MIR-4436B-5P | 96.71 | 68.37 | 1346 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 1700016H13Rik | ENSMUSG00000029320 |
| rattus_norvegicus | C14h4orf36 | ENSRNOG00000060245 |
Protein
Protein identifiers
Uncharacterized protein C4orf36 — Q96KX1 (reviewed: Q96KX1)
All UniProt accessions (5): Q96KX1, D6RAE1, D6RCP1, D6RF10, D6RGW9
RefSeq proteins (7): NP_001356817, NP_001356818, NP_001401564, NP_001401565, NP_001401567, NP_001401569, NP_653246* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027825 | DUF4522 | Family |
Pfam: PF15022
UniProt features (3 total): sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96KX1-F1 | 77.06 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
chr4q21, TGGAAA_NFAT_Q4_01, CAMPS_COLON_CANCER_COPY_NUMBER_UP, BCAT_BILD_ET_AL_UP, ATF5_TARGET_GENES, FEV_TARGET_GENES, GREB1_TARGET_GENES, GUCY1B1_TARGET_GENES, LHX9_TARGET_GENES, TASOR_TARGET_GENES, ZNF618_TARGET_GENES, ZSCAN30_TARGET_GENES, GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN, MIR6509_3P, MIR181A_2_3P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
58 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C4orf36 | PRR27 | Q6MZM9 | 630 |
| C4orf36 | CFAP299 | Q6V702 | 611 |
| C4orf36 | ODAPH | Q17RF5 | 520 |
| C4orf36 | FDCSP | Q8NFU4 | 445 |
| C4orf36 | PGPEP1 | Q9NXJ5 | 444 |
| C4orf36 | CSHL1 | Q14406 | 400 |
| C4orf36 | DYNLT3 | P51808 | 395 |
| C4orf36 | ODAM | A1E959 | 392 |
| C4orf36 | STATH | P02808 | 355 |
| C4orf36 | DYNLT1 | P63172 | 289 |
| C4orf36 | A6NFB4 | A6NFB4 | 245 |
| C4orf36 | MEDAG | Q5VYS4 | 226 |
| C4orf36 | RLN1 | P04808 | 222 |
| C4orf36 | ST6GALNAC6 | Q969X2 | 211 |
| C4orf36 | INSL4 | Q14641 | 201 |
IntAct
0 interactions, top by confidence:
BioGRID (4): C4orf36 (Affinity Capture-MS), C4orf36 (Affinity Capture-MS), C4orf36 (Affinity Capture-MS), C4orf36 (Protein-peptide)
ESM2 similar proteins: A0A1B0GVR7, A0PJW8, A2BYT2, A5FRX9, B8G1X0, C1DKL7, G3UWD5, O42659, O62953, O95567, O98453, P05899, P11690, P11794, P19718, P20920, P27975, P32544, P33482, P39971, P52776, P54446, P69516, P69517, P86209, Q02781, Q0ABH1, Q1X6Y0, Q3AMN4, Q3J8R8, Q3K5Z2, Q3MFB7, Q3ZZM0, Q537H7, Q57P89, Q5I162, Q5PHY6, Q6AY31, Q75003, Q7CQJ0
Diamond homologs: Q6AY31, Q96KX1, Q9DAA3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1761 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:86887889:GATAG:G | acceptor_gain | 1.0000 |
| 4:86887891:TAG:T | acceptor_gain | 1.0000 |
| 4:86887893:GCTGA:G | acceptor_loss | 1.0000 |
| 4:86887894:C:CC | acceptor_gain | 1.0000 |
| 4:86887894:CTGAA:C | acceptor_loss | 1.0000 |
| 4:86887895:T:A | acceptor_loss | 1.0000 |
| 4:86888119:A:AC | donor_gain | 1.0000 |
| 4:86888120:C:CC | donor_gain | 1.0000 |
| 4:86888120:CATT:C | donor_gain | 1.0000 |
| 4:86926250:C:A | donor_gain | 1.0000 |
| 4:86887890:ATAG:A | acceptor_gain | 0.9900 |
| 4:86887892:AG:A | acceptor_gain | 0.9900 |
| 4:86888114:AACTT:A | donor_loss | 0.9900 |
| 4:86888115:ACTT:A | donor_loss | 0.9900 |
| 4:86888116:CTTAC:C | donor_loss | 0.9900 |
| 4:86888117:TTACA:T | donor_loss | 0.9900 |
| 4:86888118:TACA:T | donor_loss | 0.9900 |
| 4:86888119:A:T | donor_loss | 0.9900 |
| 4:86888120:CA:C | donor_gain | 0.9900 |
| 4:86890782:A:AC | donor_gain | 0.9900 |
| 4:86890783:C:CC | donor_gain | 0.9900 |
| 4:86890828:CACGA:C | donor_gain | 0.9900 |
| 4:86890835:T:TA | donor_gain | 0.9900 |
| 4:86926226:A:AC | donor_gain | 0.9900 |
| 4:86926227:C:CC | donor_gain | 0.9900 |
| 4:86926242:TTG:T | donor_gain | 0.9900 |
| 4:86926243:TGT:T | donor_gain | 0.9900 |
| 4:86926249:T:TA | donor_gain | 0.9900 |
| 4:86926253:T:TA | donor_gain | 0.9900 |
| 4:86933393:A:AC | donor_gain | 0.9900 |
AlphaMissense
749 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:86888238:A:G | W35R | 0.884 |
| 4:86888238:A:T | W35R | 0.884 |
| 4:86887781:T:A | R111S | 0.876 |
| 4:86887781:T:G | R111S | 0.876 |
| 4:86887860:C:G | R85P | 0.859 |
| 4:86888203:G:C | F46L | 0.853 |
| 4:86888203:G:T | F46L | 0.853 |
| 4:86888205:A:G | F46L | 0.853 |
| 4:86891500:T:A | R7S | 0.833 |
| 4:86891500:T:G | R7S | 0.833 |
| 4:86887778:T:A | R112S | 0.810 |
| 4:86887778:T:G | R112S | 0.810 |
| 4:86888185:A:C | F52L | 0.794 |
| 4:86888185:A:T | F52L | 0.794 |
| 4:86888187:A:G | F52L | 0.794 |
| 4:86887782:C:G | R111T | 0.790 |
| 4:86887857:A:G | L86P | 0.750 |
| 4:86887880:T:A | E78D | 0.738 |
| 4:86887880:T:G | E78D | 0.738 |
| 4:86887868:T:A | E82D | 0.735 |
| 4:86887868:T:G | E82D | 0.735 |
| 4:86887848:A:G | L89P | 0.729 |
| 4:86888263:C:A | W26C | 0.707 |
| 4:86888263:C:G | W26C | 0.707 |
| 4:86891477:A:G | L15S | 0.703 |
| 4:86891501:C:G | R7T | 0.699 |
| 4:86888236:C:A | W35C | 0.689 |
| 4:86888236:C:G | W35C | 0.689 |
| 4:86887881:T:A | E78V | 0.688 |
| 4:86888235:A:G | S36P | 0.675 |
dbSNP variants (sampled 300 via entrez): RS1000014182 (4:86884906 C>T), RS1000149523 (4:86884578 T>G), RS1000257291 (4:86885643 A>G), RS1000285040 (4:86899602 T>C), RS1000481767 (4:86879648 A>G), RS1000555445 (4:86886587 G>A), RS1000588403 (4:86886790 G>A), RS1000785209 (4:86880753 A>G), RS1000973001 (4:86894081 T>G), RS10011798 (4:86891411 G>A,C), RS1001230733 (4:86884065 A>C), RS1001237078 (4:86894348 T>C), RS10015121 (4:86892668 C>G), RS10015477 (4:86892900 G>A,T), RS10017360 (4:86898704 C>A,G,T)
Disease associations
OMIM: gene MIM:621278 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001958_16 | Bulimia nervosa | 4.000000e-06 |
| GCST003476_4 | Eyebrow thickness | 2.000000e-06 |
| GCST005580_91 | Intraocular pressure | 5.000000e-11 |
| GCST005580_97 | Intraocular pressure | 7.000000e-11 |
| GCST009467_2 | Hemoglobin levels | 4.000000e-06 |
| GCST010243_98 | Apolipoprotein B levels | 3.000000e-10 |
| GCST90002389_188 | Lymphocyte percentage of white cells | 2.000000e-10 |
| GCST90002400_432 | Plateletcrit | 6.000000e-09 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004695 | intraocular pressure measurement |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004615 | apolipoprotein B measurement |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0007985 | platelet crit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| clothianidin | decreases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Methylcholanthrene | affects binding, increases reaction | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bulimia nervosa